UK Innovation & Science Seed Fund News

11 March 2020: GyreOx Therapeutics (GyreOx), developing its novel MACRO platform, has launched today with backing from UKI2S and LifeArc. Developing complex molecules able to target intracellular interactions, the company will develop therapy for cancer and autoimmune diseases based on research carried out by Professor James Naismith (University of Oxford, previously at the University of St […]

read more

Founded by UK Innovation & Science Seed Fund (UKI2S) with co-investment from LifeArc & Parkwalk to advance a diabetic macular edema gene therapy and other pipeline products Cambridge, February 5 2020: Ikarovec, which is developing novel gene therapies to treat major ophthalmic indications, has launched today with £2.5m of seed funding from leading UK start-up investors […]

read more

25 November 2019 A University of Bristol spin-out company has raised £1.1 million in funding to develop next generation cell therapies that could open new ways to treat solid tumours and improve the lives of 18-million people worldwide who are diagnosed with cancer each year. Presently, treatments for solid tumours, which account for most tumour […]

read more

1 2 3 4 5 32